David Cooper
25Patents
6h-index
46Co-inventors
69Inventor score
Filing activity: Oct 29, 1974 → Jul 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4265779A | Suds suppressing compositions and detergents containing them | Chemistry; Metallurgy | 51 | Expired |
| US9492559B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 36 | Active |
| US6010895A | Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat | Chemistry; Metallurgy | 13 | Expired |
| US10183070B2 | Neisseria meningitidis compositions and methods thereof | Chemistry; Metallurgy | 9 | Active |
| US10543267B2 | Neisseria meningitidis compositions and methods thereof | Chemistry; Metallurgy | 9 | Active |
| US3963695A | Tetradeoxyneamine and derivatives thereof | Chemistry; Metallurgy | 6 | Expired |
| US10653764B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 6 | Active |
| US11160855B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US11090375B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US4048430A | Mercaptopseudotrisaccharides | Chemistry; Metallurgy | 4 | Expired |
| US4049031A | Automatic fraction collector | Physics | 3 | Expired |
| US11135279B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 2 | Active |
| US4293546A | Anthracycline antibiotics produced by Streptosporangium fragilis Shearer sp. nov. ATCC 31519 | Chemistry; Metallurgy | 2 | Expired |
| US6639029B1 | Process for continuous synthesis of polymer compositions as well as use of same | Chemistry; Metallurgy | 2 | Expired |
| US9393274B2 | Control of sucking lice | Human Necessities | 2 | Active |
| US10813989B2 | Neisseria meningitidis compositions and methods thereof | Chemistry; Metallurgy | 2 | Active |
| US11413344B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 1 | Active |
| US11730800B2 | Neisseria meningitidis compositions and methods thereof | Chemistry; Metallurgy | 1 | Active |
| US4110439A | Amino glycoside antibiotics having antiprotozoal activity | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4389398A | Amino glycoside antibiotics having antiprotozoal and anthelmintic activity | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4049796A | Amino glycoside antibiotics having antibacterial activity | Emerging Cross-Sectional Technologies | 0 | Expired |
| US3960838A | Mercaptopseudodisaccharides | Chemistry; Metallurgy | 0 | Expired |
| US11872274B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12318438B2 | Immunogenic compositions for use in pneumococcal vaccines | Human Necessities | 0 | Active |
| US4385122A | Anthracycline antibiotics produced by streptosporangium fragile | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.